We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.00
Bid: 50.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 20.00 (40.00%)
Open: 60.00
High: 60.00
Low: 60.00
Prev. Close: 60.00
CLC Live PriceLast checked at -
Calculus VCT is an Investment Trust

To invest primarily in a diverse portfolio of VCT qualifying UK growth companies whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

18 Oct 2019 16:40

RNS Number : 4434Q
Calculus VCT PLC
18 October 2019
 

Calculus VCT plc

Half Yearly Report for the six months ended 31 August 2019

 

INVESTMENT OBJECTIVE

The Company's principal objectives for investors are to:

 

invest in a portfolio of Venture Capital Investments that will provide investment returns that are sufficient to allow the Company to maximise dividends and capital growth over the medium to long term;

 

generate sufficient returns from a portfolio of Venture Capital Investments that will provide attractive long-term returns within a tax efficient vehicle;

 

review and pay the appropriate level of dividends annually taking account of investment returns achieved and future prospects; and

 

maintain VCT status to enable qualifying investors to retain their income tax relief of up to 30 per cent. on the initial investment and receive tax-free dividends and capital growth.

 

FINANCIAL REVIEW

Ordinary share fund

 

Financial Highlights

6 months to

31 August 2019

6 Months to

31 August 2018

12 Months to

28 February 2019

Total return per new Ordinary share

(0.28p)

(1.63p)

(7.27p)

Net asset value per new Ordinary share

72.20p

81.10p

75.84p

 

To date, 11.65 pence of dividends have been paid to eligible Ordinary shareholders. In addition, since launch 85.24 pence has been paid to original ordinary shareholders and 75.10 pence to original C shareholders including the equivalent dividends paid since the share class merger that took place on 1 August 2017.

 

CHAIRMAN'S UPDATE

 

I am pleased to present your Company's results for the 6 months to 31 August 2019.

 

Performance summary

 

The NAV showed a 3.6p per share decrease in the 6 months to 31 August 2019. Of this decrease in value, 3.4 pence per share is attributable to the dividend that was paid in July 2019. The further movement is attributable to the performance of qualifying investments.

 

I am delighted to report that during the period, the Company's holding in Synpromics Limited was sold achieving an impressive return for investors. Whilst the financial terms of the acquisition are undisclosed, the return achieved significantly exceeds target returns. The deal is further enhanced by the potential to benefit from future licensing fees on Synpromics existing portfolio of licences.

 

AnTech has performed well in the period, increasing 30% in value since 28 February 2019. This is predominantly due to the growth of its directional drilling tools division. Money Dashboard has increased in value by 20% in the period as it has improved its market position following a funding round in July 2019.

 

Although many companies in the portfolio showed strong growth, the Company's NAV was hit by the write down of some investments. Terrain Energy was written down by £265,000 due to the disappointing results of the Brockham well test. Solab's equity was written down in full losing £180,000 of NAV value when the company was put in administration in June 2019. The value of Pico's (Benito's Hat) has also been written down as the company is continuing to experience difficult trading conditions. In addition, the current economic and political uncertainty in the UK which has led to weak performance of the public markets has also impacted the few AIM quoted holdings in the portfolio.

 

The NAV also suffered from the low return earned on cash and near cash balances held by the Company awaiting investment. The Company has an active investment programme and funds are now being put to work.

 

In the period to 31 August 2019, six new investments were made on behalf of the qualifying portfolio:

 

- March 2019: the Company invested an additional £100,000 in WheelRright Limited

- April 2019: £300,000 was invested in Wazoku Limited

- April 2019: £300,000 was invested in existing portfolio company Blu Wireless Technologies Limited

- May 2019: the Company invested £340,000 in IPV Limited

- May 2019: the Company invested a further £200,000 in Every1Mobile Limited

- July 2019: the Company invested a further £150,000 in Quai Administration Services Limited

 

Further information can be found on new investee companies Wazoku Limited and IPV Limited in the Investment Manager's Report.

 

Buybacks

 

During the period, the Company bought back and cancelled 78,279 Ordinary shares. The Company continues to review opportunities to carry out share buybacks at a discount of no greater than 10% to NAV.

 

Dividends

 

As mentioned above, a dividend was paid on 26 July 2019 of 3.4 pence per eligible Ordinary share.

 

Board composition

 

Michael O'Higgins stepped down from the board following the AGM in July 2019 and I was appointed Chairman from that date. I would like to thank Michael for his contribution to the VCT over the past 10 years.

 

Change of auditor

 

The Company appointed BDO LLP to take over from Grant Thornton in May 2019 after carrying out a tender process. BDO LLP were then elected by shareholders at the Annual General Meeting on 4 July 2019.

 

Ordinary share issue

 

The offer for subscription for Ordinary Shares that opened on 13 September 2018 and closed on 31 August 2019 received aggregate subscriptions from the issue of Ordinary shares of £5.9 million.

 

On 24 September 2019 a new prospectus was launched for a further offer for subscription for Ordinary Shares, with the shares to be issued in the 2019/20 and 2020/21 tax years.

 

Developments since the period end

 

On 6 September 2019, the Company issued 1,334,399 Ordinary Shares under the prospectus approved on 13 September 2019. The Company subsequently launched a new offer 24 September 2019.

 

Other than mentioned above, there have been no material developments since the period end.

 

 

Jan Ward

Chairman

18 October 2019 

 

INTERIM MANAGEMENT REPORT

 

Venture Capital Investments

 

Portfolio developments

 

Calculus Capital Limited manages the Company's portfolio of venture capital investments. In general, Calculus Capital prefers investments to be of a sufficient size to enable them to play an influential role in helping the investee companies develop. Investments by the Company may be by way of equity, and also by way of loan stock and/or preference shares which provide income to assist in paying dividends and provide a measure of risk mitigation.

 

As at 31 August 2019, the portfolio had 31 Qualifying Investments. An update on some of the portfolio companies has been provided below.

 

AnTech Limited

AnTech is a specialist engineering company in the oil and gas market, manufacturing products for use in oil and gas production, as well as providing directional coiled tube drilling services. The Products Division supplies high specification customised and standard products. The division is on track for a record year, with current sales and the order book bolstered by continued oil price stabilisation. AnTech's Services Division has developed a new generation of directional drilling tools, which transforms the manner and efficiency with which oil and gas wells can be drilled with coiled tubing. Following a period of slowly gaining market acceptance, the division is showing promising signs of growth, with a bigger and better pipeline than previously. AnTech has managed its resources, including cash, well and is optimistic about the prospects for both its divisions.

 

Arcis Biotechnology Holdings Limited

Arcis has developed an innovative way of extracting DNA and potentially RNA which has significant advantages over other techniques. Arcis' patented sample preparation system simply and rapidly opens up human cells, microorganisms, viruses and fungi to release the DNA / RNA and, unlike competitor processes, the Arcis chemistry more effectively protects the DNA / RNA from degradation. Arcis has signed its first commercial license agreement providing its technology in the development of a rapid diagnostic test. The initial progress of this collaboration has been positive. In July 2019 Arcis received a £1.2m investment from new and existing investors. The funds will be used to further support the company's product development and commercialization efforts.

 

Arecor Limited

Arecor, with a proprietary technology platform, partners with major global pharmaceutical and biotech companies in a licencing model to deliver superior reformulations of their proprietary products, which would not be possible using conventional formulation science. Arecor is also leveraging its platform to develop its own portfolio of products, initially focused on improving the treatment of diabetes. Since the investment by Calculus VCT, as part of a £6m round, the company has appointed a new CFO, Susan Lowther, who has significant experience across both private and public fast-growing life science companies. In March 2019, in line with its plan, Arecor announced that its Phase I clinical trial application for its ultra-rapid acting insulin product has been approved by the Austrian regulator. The trial is being conducted in Austria at an internationally recognised centre of excellence in the field of diabetes research and results are expected later in 2019.

 

 

 

Blu Wireless Technology Limited

The Company invested £300,000 in Blu Wireless Technology (BWT) in April 2019. BWT is a key player in the development of high frequency (mmWave) wireless communication, which allows for multi-gigabit per second data transfer with low latency has been heralded as the future for ultra-fast wireless technology. Key market applications include: reducing the cost of building dense 5G networks by providing backhaul through fixed wireless access (FWA); and reliable high-speed connectivity for high speed trains and vehicles. BWT is a key part of two UK government contracts as part of the UK's 5G Strategy, including in Liverpool to support the NHS and its high-speed transport technology is being used in the Auto Air Testbed. In February 2019, BWT announced a partnership with FirstGroup, to deliver high speed internet to trains both in the UK and overseas. In April 2019, BWT completed a £12.6m funding round, in which Calculus VCT participated alongside ARM (formerly Arm Holdings) and other new institutional investors.

 

Cloud Trade Technologies Limited

Cloud Trade is a software company providing technology that allows businesses to automate the invoice handling process in a way that is completely invisible to the supplier. Invoices are simply directed to a new email address, allowing Cloud Trade's patented software to automatically extract the relevant data and inject it directly into the accounting system. Today, Cloud Trade's software is primarily used to automate the accounts payable process, but the technology is applicable to any computer-generated document. With the rise of robotic process automation (RPA) systems, Cloud Trade's addressable market is expected to expand significantly. Since the investment by Calculus, the company has appointed a new Chairman, Philip Padfield, and a new Chief Revenue Officer, Steve Emecz, established a US entity (Cloud Trade Inc.) and launched Cloud Trade Logistics; a specialised product for the US freight logistics industry. Cloud Trade has progressed well over recent months with new customers won in the US (Cloud Trade Logistics), the UK and Europe. In June 2019, Cloud Trade launched on the Systems Applications and Products ("SAP®") App Center, the digital marketplace for SAP partner offerings, which is expected to be an important future sales channel.

 

Essentia Analytics Limited

Essentia Analytics provides decision analytics in order to improve the performance of active asset managers. Essentia's proprietary software conducts full algorithmic analysis of all past investment decisions, and using machine learning identifies each individual portfolio manager's behavioural biases. The software then continuously monitors their portfolio including individual stock performance and trading and creates proactive behavioural 'nudges' to help the fund manager improve his or her performance. Quarterly consultation sessions are also provided to reinforce change in behavioural trading biases at an individual and team level. Its customers include large US, UK and European asset management companies as well as hedge funds. In January 2019, Calculus invested £2.5m in the company, which is being used to expand their product offering, in particular for asset allocators (CIOs), and to drive growth by strengthening the US and European sales and marketing capability.

 

Every1Mobile Limited

The Company invested £200,000 in Every1Mobile ('E1M') in May 2019 bringing the total investment to £400,000. In 2018, E1M grew revenues by 60%, and won several major contracts, including its first Software-as-a-Service (SaaS) licensing contract for delivery of online business education services to micro-entrepreneurs across Unilever's worldwide emerging markets. Its platform also connects 3,200 shopkeepers and 13,000 consumers in Kenya and Nigeria as part of public-private partnership between Unilever, DFID and the Bill & Melinda Gates Foundation. These partnerships are designed to build the businesses of low-income shopkeepers via education and access to services, such as consumer vouchering. In February 2019, DeafKidz International and E1M announced a partnership to develop an online platform for emerging markets worldwide that will enable professionals, such as teachers, police, social workers and health workers, to access online training and resources and access peer and expert support through their mobile phone.

 

IPV Limited

The Company invested £340,000 in IPV during the period: £40,000 of equity and £300,000 of loan notes. IPV's proprietary software enables companies to access, store, modify, tag and transfer video content quickly and efficiently, significantly improving internal processes and creating more routes to market. IPV's products are designed to create a "Content Factory" experience for the users, streamlining the creative editorial process and the delivery of content to multiple platforms. IPV has an established, blue chip customer base in the media and broadcast industry, including Turner, Sony Entertainment, the Oscars (AMPAS) and Sky. IPV continues to move from its historical "perpetual licence" model to a subscription and hosted, recurring revenue model. The change has resulted in relatively flat total revenues over recent periods, but strong growth in the more valuable, recurring revenue stream. In 2018, total revenues fell slightly compared to the prior year, but more valuable recurring revenue increased by 60% from £1m to £1.6m over the same period. Focus for the next twelve months is to continue increasing the recurring revenues.

 

MicroEnergy Generation Services Limited

MicroEnergy Generation Services owns and operates a fleet of 147 small onshore wind turbines (

 

Money Dashboard Limited

Money Dashboard offers its users a free view of their finances (from bank accounts, credit cards, store cards, etc.) in one secure place. The company's proprietary transaction tagging technology analyses the user's spending into categories, providing an automatically updating, consolidated view of their financial lives. Money Dashboard's principal revenue stream is based upon aggregating its users' data on an anonymous basis to analyse consumer spending trends, which can be sold to institutional investors and others. In August 2019, Calculus Capital invested a further £1.0m (as part of a £4.6m round) which will be used to support additional recruitment, as well as to further develop the company's technological offering, helping cement the company's market leading position.

 

Open Orphan plc (formerly Venn Life Sciences)

In May 2019 the Board of Directors of Venn Life Sciences, an integrated Contract Research Organisation providing drug development, clinical trial management and resourcing solutions, recommended the company enter into a reverse takeover transaction with Open Orphan, a services platform for pharmaceutical and biotechnology companies with a particular focus on drugs for rare diseases, which have been designated as "Orphan Drugs''. Open Orphan has built a database connecting over 4,000 rare disease specialist physicians with over 500 pharmaceutical companies with orphan drugs in development or on the market across Europe. Open Orphan has also begun establishing a patient health data platform, with a focus on rare diseases. Venn Life Sciences' service offerings will enable the combined group to assist the developers of rare disease and orphan products from pre-clinical development through to commercialisation. The combined group aims to build a leading, European-focussed, rare and orphan drug consulting services platform, building on its existing capability through strategic and targeted acquisitions.

 

Oxford BioTherapuetics Limited

Oxford BioTherapeutics (OBT) is a clinical stage oncology company committed to the discovery and development of novel therapies for various cancer types. OBT has a number of partnered programs, as well as a strong pipeline of proprietary immune-oncology (IO) therapies, which are used to re-engage and recruit the body's immune system to attack cancer cells. In June 2019, OBT received a milestone payment from Boehringer Ingelheim (BI) in relation to the advancement of one of two pre-clinical stage candidates, which BI is developing. In addition, the most advanced of OBT's two clinical stage assets, which are both being funded by The Menarini Group through to completion of Phase II, has begun clinical development in the US for patients with high risk breast cancer and other solid tumours. In August 2019, OBT received an investment of $5m from ALSA Ventures, a life sciences investor focused on novel therapeutics.

 

 

Park Street Shipping Limited

In February 2017, Park Street Shipping purchased MV Nordic London, a 2010 South Korean built 35,000 dwt Handysize dry bulk carrier, taking advantage of the attractive investment environment in the sector. The company recently secured a 7-10-month charter with Cargill, the largest privately held corporation in the United States in terms of revenue, at USD 10,300 per day. This is the same day rate as the previous charter which was secured when the market was stronger suggesting that the vessel is performing well and in demand. Mid-term prospects for the sector are encouraging with fleet growth expected to be approximately 2% versus dry bulk demand growth of 3%, although ongoing risks to the sector persist due to international trade disputes. The valuation has been increased since the last valuation date due to the strength of the USD against the GBP as the vessel earns income in USD.

 

Pico's Limited ("Benito's Hat")

Benito's Hat is a Mexican-themed fast casual restaurant business with eight sites. As has been widely reported, trading in the casual dining market is challenging at present. A new site model was established to adapt to the current environment, reducing new build costs and giving the brand the ability to open smaller stores. Whilst this work has been necessary, it has meant that the business incurred a number of one-off costs. Combined with the slower than expected maturity of newly opened stores, this led to a deterioration in cashflow. Having taken advice from restructuring experts the company took the decision to pursue a Company Voluntary Arrangement ("CVA"). The proposal was approved with 93% of creditors voting in favour. While negotiations with landlords are ongoing and will be key to building a sustainable business, the company is focusing on initiatives to protect revenues in the current volatile consumer spending environment. Management is focused on achieving a sustainable level of profitability before pursuing an exit opportunity for shareholders.

 

Quai Administration Services Limited

The Company invested £150,000 in Quai in July 2019. Quai's platform administers thousands of individual savings plans at a fraction of the cost incurred by established insurance companies and wealth managers, with the company's compliant and efficient administration systems providing clients with the ability to drive operational efficiencies. Quai's systems focus on the provision of two core administration services: Product Administration for mass-market consumer offerings and Portfolio Administration for private client and portfolio managers. Since Calculus' initial investment, Quai's revenues have grown by nearly 300% (over 30% compound annual growth). Quai now has 11 customers live on its platform including PJMilton, Punter Southall, Digital Moneybox and Tavistock Investments. In the coming year Quai is reviewing the possibility of applying for its own FCA permissions, which would expand the company's range of services, increase margins and reduce reliance on third parties for a key service.

 

Terrain Energy Limited

Terrain has interests in four production licences and seven exploration licences. Terrain's most promising assets are its 100% owned and operated exploration licences in Germany with recoverable resources estimated at 23 billion cubic feet (bcf) of gas and 3.1 million barrels of oil. Three geothermal wells have been drilled on and adjacent to these licences in recent years targeting water and have made significant hydrocarbon discoveries thus de-risking the assets for Terrain. Terrain's near-term focus is maximising cash flow from its production and development assets in order to support the delivery of its German appraisal blockbuster in the mid-term, but it is not without risk. The Brockham well was tested in June 2019 with the conclusion that oil could not be produced from the Kimmeridge formation at commercial levels. This, alongside continuing operational issues at the Whisby field, has reduced the company's value. The Directors are examining the prospect of an exit event in the short-medium term, depending on market conditions.

 

Wazoku Limited

Calculus VCT invested £300,000 in Wazoku Ltd in April 2019 as part of £2.5m investment round. Wazoku has developed a market leading platform and suite of support services to enable firms to innovate at scale. The core product, Idea Spotlight, is a Global Home for Ideas. It is a customisable off-theshelf solution offering collaborative idea management modules to meet the diverse set of innovation requirements that global businesses have. Successful innovation requires not only capturing ideas, but also collating, analysing and implementing them. The platform provides the process and structure to capture, evolve, evaluate, develop, measure, select and implement the best ideas from internal or external stakeholders. Wazoku has an impressive client list including John Lewis, Aviva, HSBC, Oxford University and Bristol-Myers Squibb.

 

Weeding Technologies Limited ("Weedingtech")

Weedingtech is a cleantech company focused on replacing toxic herbicides, particularly in the municipal market. Weedingtech's technology treats weed and moss using environmentally friendly hot foam (which keeps the heat on long enough to kill the weed or moss). The last twelve months have seen increased legal and public focus on the use of chemical herbicides, particularly in public areas. There have been a number of very large court awards against Monsanto in relation to the use of glyphosate and an estimated 11,000 further US cases are pending. In April 2019, with Calculus Capital's support, Weedingtech secured a £2.2m funding round from a new institutional investor specialising in environmental sustainability. The funds will be used for the continued expansion into the US, sales and marketing and operational improvements.

 

Developments since the period end

 

Other than as disclosed above, there have been no developments since the period end.

 

 

 

 

Calculus Capital Limited

18 October 2019

 

INVESTMENT PORTFOLIO AS AT 31 AUGUST 2019

- TOTAL FUND

 

% of Net Assets

 

 

Unquoted - loan stock

10%

Quoted and unquoted - ordinary and preference shares

37%

Unquoted - liquidity funds

38%

Net current assets

15%

 

100%

 

 

 

Asset class - % of Portfolio

 

 

 

 

Quoted and unquoted - Qualifying Investments

55%

 

Unquoted - other non-Qualifying Investments

45%

 

 

100%

 

 

 

 

 

 

 

 

 

 

 

Book Cost

Valuation

Movement since 28 Feb 19

%

of

Company

Nature of Business

£'000

£'000

%

Portfolio

Qualifying Investments

 

 

 

 

 

Air Leisure Group Limited

Leisure

200

-

-

-

AnTech Limited

Oil services

120

186

30%

1

Arcis Biotechnology Holdings Limited

Med Tech

275

275

-

2

Arecor Limited

Biotech

100

114

14%

1

Blu Wireless Technology Limited

Technology Hardware

450

745

67%*

6

C4X Discovery Holdings plc

Pharma Services

199

84

(42%)

1

Cloud Trade Technologies Limited

Software

200

249

8%

2

Cornerstone Brands Limited

E-commerce

150

150

-

1

Duvas Technologies Limited

Oil & Gas Services

208

198

(5%)

1

Essentia Analytics Limited

Technology Services

200

219

9%

2

Every1Mobile Limited

Technology Services

400

430

-*

3

Genedrive plc

Biotech

144

44

(35%)

-

Infrastrata plc

Gas Utilities

2

1

(66%)

-

IPV Limited

Technology Software

340

340

New

3

MicroEnergy Generation Services

Energy

148

77

7%

1

MIP Diagnostics

Biotech

200

240

-

2

Mologic Limited

Med Tech

200

266

-

2

Money Dashboard Limited

Personal Finance

277

332

20%

2

Open Energy Market Limited

Technology Services

200

230

-

2

Open Orphan plc

Clinical Research

55

15

87%

-

Oxford Bio Therapeutics Limited

Biotech

200

243

21%

2

Park Street Shipping Limited

Shipping

150

218

9%

2

Pico's Limited

Leisure

199

103

(43%)

1

Quai Administration Services Limited

Technology

370

370

-*

3

Scancell Holdings plc

Biotech

378

178

(3%)

1

Solab Group Limited

Cosmetics

479

295

(38%)

2

Terrain Energy Limited

Oil & gas production

967

616

(30%)

5

Tollan Energy Limited

Energy

13

12

-

-

Wazoku Limited

Technology Software

300

349

New

3

Weeding Technologies Limited

Technology Hardware

216

258

11%

2

WheelRight Limited

Industrials Engineering

300

300

-*

2

Total Qualifying Investments

 

7,640

7,137

 

55

Other non-Qualifying Investments

 

 

 

 

 

Aberdeen Sterling Liquidity Fund

Liquidity fund

1,882

1,882

 

15

Fidelity Sterling Liquidity Fund

Liquidity fund

1,883

1,897

 

15

Goldman Sachs Sterling Liquidity Fund

Liquidity fund

1,880

1,880

 

15

Terrain Energy Limited

Oil and gas production

5

3

 

-

Total Other non-Qualifying Investments

 

5,650

5,662

 

45

Total Investments

 

13,290

12,799

 

100

Net Current Assets less Creditors due after one year

 

 

2,193

 

 

Net Non-Current Assets less Creditors due after one year

 

 

4

 

 

Net Assets

 

 

14,996

 

 

        

 

*Where additions have been made to existing holdings in the period, the movement includes the additional cost as if the additional investment had been held at the year end.

 

PRINCIPAL RISKS

The principal risks facing the Company remain the same as those detailed on page 25 of the Annual Report and Accounts for the year ended 28 February 2019.

 

Brexit is still causing uncertainty however it remains our view that our portfolio companies are not experiencing material difficulties as a result of the political situation.

 

The main risks faced by the Company include, but are not limited to, loss of approval as a venture capital trust and other regulatory breaches, risks of making and realising qualifying investments, liquidity/marketability risk, changes in legislation/taxation, engagement of third party advisers, market price risk and credit risk.

 

GOING CONCERN

 

After making enquiries, and having reviewed the portfolio, balance sheet and projected income and expenditure for the next twelve months, the Directors have a reasonable expectation that the Company has adequate resources to continue in operation for the foreseeable future. The Directors have therefore adopted the going concern basis in preparing these condensed financial statements.

 

DIRECTORS' RESPONSIBILITY STATEMENT

 

The half-yearly financial report has been reviewed by the Company's auditors. This report is the responsibility of, and has been approved by, the Directors. The Directors confirm that to the best of their knowledge the half-yearly financial report, which has been prepared in accordance with the UK Listing Authority Disclosure and Transparency Rules ("DTR") and in accordance with the Financial Reporting Council's Financial Reporting Standard 104: 'Interim Financial Reporting' gives a true and fair view of the assets, liabilities, financial position and the net return of the Company as at 31 August 2019.

 

The Directors confirm that the Chairman's Update, the Investment Management report, the disclosures above and notes 10 and 11, include a fair review of the information required by DTR 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year, and DTR 4.2.8R.

 

The Directors of Calculus VCT plc are:

Jan Ward

Kate Cornish-Bowden

Claire Olsen

John Glencross

 

By order of the Board

 

Jan Ward

Chairman, 18 October 2019

 

 

 

 

CONDENSED INCOME STATEMENT

FOR THE PERIOD FROM 1 MARCH 2019 TO 31 AUGUST 2019 (UNAUDITED)

 

 

 

 

6 Months Ended

6 Months Ended

12 Months Ended

 

 

31 August 2019

31 August 2018

28 February 2019

 

 

Revenue

Capital

 

Revenue

Capital

 

Revenue

Capital

 

 

 

 Return

Return

Total

 Return

Return

Total

 Return

Return

Total

 

Note

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

 

Investment holding losses

8

-

(50)

(50)

-

(174)

(174)

-

(612)

(612)

Gain/(loss) on disposal of investments

 

8

 

-

 

154

 

154

 

-

 

104

 

104

 

 -

 

(88)

 

(88)

Income

 

77

-

77

42

-

42

91

-

91

Investment management fee

 

(32)

(98)

(130)

(24)

(72)

(96)

(49)

 

 

(148)

(197)

Other operating expenses

 

(107)

 

 

-

 

 

(107)

(93)

 

 

-

 

 

(93)

(221)

 

 

-

(221)

 

 

 

 

 

 

 

 

 

 

 

(Loss)/profit on ordinary activities before taxation

 

(62)

 

 

 

 

6

 

 

 

 

(56)

(75)

 

 

 

 

(142)

 

 

 

 

(217)

(179)

(848)

(1,027)

 

 

 

 

 

 

 

 

 

 

 

Taxation on ordinary activities

3

-

-

-

-

-

-

-

-

-

 

 

 

 

 

 

 

 

 

 

 

(Loss)/profit for the period

 

(62)

 

6

 

(56)

(75)

 

(142)

 

(217)

 

(179)

 

(848)

 

(1,027)

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted deficit per new Ordinary share

 

2

 

(0.31)p

 

0.03p

 

(0.28)p

 

 (0.56)p

 

(1.07)p

 

(1.63)p

 

(1.27)p

 

(6.00)p

 

(7.27)p

 

 

 

 

 

 

 

 

 

 

 

The supplementary revenue return and capital return columns are both prepared in accordance with the Association of Investment Companies ("AIC") Statement of Recommended Practice ("SORP"). No operations were acquired or discontinued during the period. All items in the above statements derive from continuing operations. There were no recognised gains or losses other than those passing through the Income Statement. The notes form an integral part of these condensed financial statements.

 

 

 

CONDENSED STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD FROM 1 MARCH 2019 TO 31 AUGUST 2019 (UNAUDITED)

 

 

 

 

 

Non-distributable reserves

Distributable reserves

 

 

 

Share

 

Capital

Capital 

Capital 

 

 

 

Share

Premium

Special 

Redemption

Reserve 

Reserve 

Revenue 

 

 

Capital

Account

Reserve 

Reserve

Realised 

Unrealised 

Reserve 

Total 

 

£'000

£'000

£'000 

£'000 

£'000 

£'000 

£'000 

£'000 

For the 6 month period to 31 August 2019

 

 

 

 

 

 

 

 

1 March 2019

184

5,584

9,488

56

215

(441)

(1,115)

13,971

Investment holding losses

-

-

-

-

-

(50)

-

(50)

Gain on disposal of investments

-

-

-

-

154

-

-

154

New share issue

24

1,881

-

-

-

-

-

1,905

Expenses of share issue

-

(37)

-

-

-

-

-

(37)

Share buybacks for cancellation

(1)

-

(54)

1

-

-

-

(54)

Management fee allocated to capital

-

-

-

-

(98)

-

-

(98)

Change in accrual in IFA Commission

-

(24)

-

-

-

-

-

(24)

Revenue return after tax

-

-

-

-

-

-

(62)

(62)

Dividends paid (note 9)

-

-

(709)

-

-

-

-

(709)

31 August 2019

207

7,404

8,725

57

271

(491)

(1,177)

14,996

For the 6 month period to 31 August 2018

 

 

 

 

 

 

 

 

1 March 2018

116

298

9,974

56

451

171

(936)

10,130

Investment holding gains

-

-

-

-

-

(174)

-

(174)

Gain on disposal of investments

-

-

-

-

104

-

-

104

New share issue

30

2,474

-

-

-

-

-

2,504

Expenses of share issue

-

(90)

-

-

-

-

-

(90)

Share buybacks for cancellation

-

-

(7)

-

-

-

-

(7)

Management fee allocated to capital

-

-

-

-

(72)

-

-

(72)

Change in accrual in IFA Commission

-

(38)

-

-

-

-

-

(38)

Revenue return on ordinary activities after tax

-

-

-

-

-

-

(75)

(75)

Dividend paid (note 9)

-

-

(451)

-

-

-

-

(451)

31 August 2018

146

2,644

9,516

56

483

(3)

(1,011)

11,831

 

 

 

 

 

 

 

 

 

 

 

 

CONDENSED STATEMENT OF CHANGES IN EQUITY

(CONTINUED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-distributable reserves

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Distributable reserves

 

 

 

 

 

 

Share

 

Capital

Capital 

Capital 

 

 

 

Share

Premium

Special 

Redemption

Reserve 

Reserve 

Revenue 

 

 

Capital

Account

Reserve 

Reserve

Realised 

Unrealised 

Reserve 

Total 

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

For the 12 months to 28 February 2019*

 

 

 

 

 

 

 

 

1 March 2018

116

298

9,974

56

451

171

(936)

10,130

Investment holding losses

-

-

-

-

-

(612)

-

(612)

Loss on disposal of investments

-

-

-

-

(88)

-

-

(88)

New share issue

68

5,446

-

-

-

-

-

5,514

Expenses of share issue

-

(98)

-

-

-

-

-

(98)

Share buybacks for cancellation

-

-

(35)

-

-

-

-

(35)

Management fee allocated to capital

-

-

-

-

(148)

-

-

(148)

Change in accrual in IFA commission

-

(62)

-

-

-

-

-

(62)

Revenue return after tax

-

-

-

-

-

-

(179)

(179)

Dividends paid

-

-

(451)

-

-

-

-

(451)

28 February 2019

184

5,584

9,488

56

215

(441)

(1,115)

13,971

           

 

 

* These figures are audited.

 

 

 

CONDENSED BALANCE SHEET

AS AT 31 AUGUST 2019

(UNAUDITED)

 

 

31 August 2019

31 August 2018 

28 February 2019* 

 

Note

£'000

£'000

£'000

 

 

 

 

 

 

 

 

 

 

Fixed assets

 

 

 

 

Investments

8

12,799

11,015

11,593

Debtors

 

92

-

-

 

 

12,891

11,015

11,593

 

 

 

 

 

Current assets

 

 

 

 

Debtors

 

136

47

1,417

Cash at bank and on deposit

 

2,200

950

1,176

 

 

2,336

997

2,593

 

 

 

 

 

Creditors: amounts falling due within one year

Creditors

 

 

(143)

 

(130)

 

(145)

Net current assets

 

2,193

867

2,448

Total assets less current liabilities

 

15,084

11,882

14,041

 

 

 

 

 

Creditors: amounts falling due after more than one year

 

 

 

 

IFA trail commission

 

(88)

(51)

(70)

 

 

 

 

 

Total net assets

 

14,996

11,831

13,971

 

 

 

 

 

Capital and reserves

 

 

 

 

Called-up share capital

6

207

146

184

Share premium account

 

7,404

2,644

5,584

Special reserve

 

8,725

9,516

9,488

Capital redemption reserve

 

57

56

56

Capital reserve - realised

 

271

483

215

Capital reserve - unrealised

 

(491)

(3)

(441)

Revenue reserve

 

(1,177)

(1,011)

(1,115)

Total shareholders' funds

 

14,996

11,831

13,971

 

 

 

 

 

Net asset value per new Ordinary share - basic

4

72.20p

81.10p

75.8p

* These figures are audited. The notes form an integral part of these condensed financial statements. 

 

CONDENSED STATEMENT OF CASH FLOW

FOR TO THE PERIOD FROM 1 MARCH 2019 TO 31 AUGUST 2019

(UNAUDITED)

 

 

6 Months 

6 Months 

12 Months

 

 

Ended 

Ended 

 Ended 

 

 

31 August 

31 August 

28 February 

 

 

2019 

2018 

2019*

 

Note

£'000 

£'000 

£'000 

 

 

 

 

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Investment income received

 

18

33

47

Deposit interest received

 

4

2

3

Investment management fees paid

 

(111)

(87)

(190)

Other cash payments

 

(144)

(114)

(213)

Net cash flow from operating activities

5

(233)

(166)

(353)

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Purchase of investments

 

(1,390)

(3,357)

(6,057)

Sale of investments

 

196

254

1,746

Net cash flow from investing activities

 

(1,194)

(3,103)

(4,311)

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Shares issued

 

3,262

2,504

4,157

Expenses of share issues

 

(41)

(90)

(94)

IFA trail commission

 

(7)

(4)

(4)

Share buybacks for cancellation

 

(54)

(7)

(35)

Equity dividend paid

9

(709)

(451)

(451)

Net cash flow from financing activities

 

2,451

1,952

3,573

Increase/(decrease) in cash and cash equivalents

 

1,024

(1,317)

(1,091)

Opening cash and cash equivalents

 

1,176

2,267

2,267

Net cash increase/(decrease)

 

1,024

(1,317)

(1,091)

Closing cash and cash equivalents

 

2,200

950

1,176

* These figures are audited. The notes form an integral part of these Accounts.

 

CONDENSED NOTES TO THE ACCOUNTS

 

1. Nature of Financial Information

 

The unaudited half-yearly financial information does not constitute statutory financial statements as defined in Section 434 of the Companies Act 2006 and has not been reviewed nor audited by the auditors. This information has been prepared on the basis of the accounting policies used in the statutory financial statements of the Company for the year ended 28 February 2019, and in accordance with FRS 104. The statutory financial statements for the year ended 28 February 2019, which contained an unqualified auditors' report, have been lodged with the Registrar of Companies, did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying the report and did not contain statements under Section 498(2) or (3) of the Companies Act 2006.

 

2. Return per Share

 

 

6 Months Ended

6 Months Ended

12 Months Ended

 

31 August 2019

31 August 2018

28 February 2019

 

Revenue 

Capital

Total

Revenue

Capital

Total 

Revenue 

Capital

Total

 

pence 

pence

pence

pence

pence

pence 

pence 

pence

pence

 

 

 

 

 

 

 

 

 

 

Return per Ordinary share

 

(0.3)

 

-

 

(0.3)

 

(0.6)

 

(1.1)

 

(1.7)

 

(1.3)

 

(6.0)

 

(7.3)

           

 

New Ordinary shares

 

 

Revenue return per Ordinary share is based on the net revenue loss on ordinary activities after taxation of £62,180 and on 20,217,168 Ordinary shares, being the weighted average number of Ordinary shares in issue during the period.

 

Capital return per Ordinary share is based on the net capital gain for the period of £6,118 and on 20,217,168 Ordinary shares, being the weighted average number of Ordinary shares in issue during the period.

 

Total return per Ordinary share is based on the net loss on ordinary activities for the period of £56,062 and on 20,217,168 Ordinary shares, being the weighted average number of Ordinary shares in issue during the period.

 

 

3. Taxation on Ordinary Activities

 

The estimated effective tax rate at the period end is 0 per cent. This remains unchanged from the prior year end.

 

 

 

 

4. Net Asset Value per Share

 

 

31 August

31 August

28 February

 

2019

2018

2019

 

pence

Pence

Pence

 

 

 

 

Net asset value per new Ordinary share

72.2

81.1

75.8

 

The basic net asset value per new Ordinary share is based on net assets (including current period revenue) of £14,996,000 and on 20,770,422 Ordinary shares, being the number of new Ordinary shares in issue at the period end.

 

 

 

5. Reconciliation of Net Profit before Tax to Cash Flow from Operating Activities

 

 

31 August 

31 August 

28 February 

 

2019 

2018 

2019 

 

£'000 

£'000 

£'000 

Ordinary Share Fund

 

 

 

 

 

 

 

Loss on ordinary activities before tax

(56)

(217)

(1,027)

(Gain)/loss on investments

(104)

70

700

Increase in debtors

(75)

(3)

(16)

Increase/(decrease) in creditors

2

(16)

(10)

 

 

 

 

Cash flow from operating activities

(233)

(166)

(353)

 

 

6. Called up share capital

 

 

31 August

 

 

2019

 

Number

£'000

 

 

 

Ordinary shares of 1p each

20,770,422

207

 

In April 2019 the Company issued 2,076,361 Ordinary shares for a total consideration of £1,630,725. In June 2019, 349,967 shares were issued for total consideration of £274,375.

 

In August 2019, the Company bought back and cancelled 78,279 shares.

 

Following the issues and cancellation noted above there were 20,770,422 Ordinary shares in issue as at 31 August 2019.

 

7. Contingent assets and contingent liabilities

 

There were no contingent assets or contingent liabilities in existence at 31 August 2019 (31 August 2018: £nil, 28 February 2019: £nil).

 

 

 

8. Fair Value Hierarchy

 

Investments held at fair value through profit or loss are valued in accordance with IPEV guidelines.

 

The valuation method used will be the most appropriate valuation methodology for an investment within its market, with regard to the financial health of the investment and the IPEV guidelines. As required by the Standard, an analysis of financial assets and liabilities, which identifies the risk of the Company's holding of such items is provided. The Standard requires an analysis of investments carried at fair value based on the reliability and significance of the information used to measure their fair value.

 

In order to provide further information on the valuation techniques used to measure assets carried at fair value, we have categorised the measurement basis into a "fair value hierarchy" as follows:

 

- Quoted market prices in active markets - "Level 1"

Inputs to Level 1 fair values are quoted prices for identical asset in an active market. Quoted in an active market in this context means quoted prices are readily and regularly available and those prices represent actual and regularly occurring market transactions on an arm's length basis. The quoted price is usually the current bid price. The Company's investments in AIM quoted equities and money market funds are classified within this category.

 

- Valued using models with significant observable market inputs - "Level 2"

Inputs to Level 2 fair values are inputs other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly.

 

- Valued using models with significant unobservable market inputs - "Level 3"

Inputs to Level 3 fair values are unobservable inputs for the asset. Unobservable inputs may have been used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset at the measurement date (or market information for the inputs to any valuation models). As such, unobservable inputs reflect the assumptions the Company considers that market participants would use in pricing the asset. The Company's unquoted equities and loan stock are classified within this category. Unquoted investments are valued in accordance with the IPEVCA guidelines.

 

 

Level 1

Level 2

Level 3

Total

 

£'000

£'000

£'000

£'000

 

 

 

 

 

Ordinary Share Fund

 

 

 

 

 

 

 

 

 

Opening book cost

6,422

-

5,612

12,034

Opening unrealised depreciation

(362)

-

(79)

(441)

Opening valuation

6,060

-

5,533

11,593

 

 

 

 

 

Movements in the period:

 

 

 

 

Purchase at cost

-

-

1,390

1,390

Sales - proceeds

-

-

(288)

(288)

Sales - realised gains on sales

-

-

154

154

Unrealised gains realised during the period

 

-

 

-

 

32

 

32

Unrealised investment losses

(78)

-

(4)

(82)

Closing valuation

5,982

-

6,817

12,799

 

 

 

 

 

Closing book cost

6,422

-

6,868

13,290

Closing unrealised depreciation

(440)

-

(51)

(491)

Closing valuation

5,982

-

6,817

12,799

 

 

 

 

 

 

During the period there were no transfers between Levels 1, 2 or 3.

 

 

 

9. Dividends

 

For the year to 28 February 2019, the Ordinary Share Fund declared a final dividend of 3.4p per share on 20,848,701 eligible shares amounting to £708,852. The dividend was paid on 26 July 2019.

 

 

10. Transactions with Related Parties

 

John Glencross, a Director of the Company, is considered to be a related party due to his position as Chief Executive and a director of Calculus Capital Limited, the Company's Investment Manager.

 

Calculus Capital Limited receives an investment manager's fee from the Company. For the 6 months to 31 August 2019, Calculus Capital Limited earned £130,091 (31 August 2018: £95,748; 28 February 2019: £197,314). Calculus Capital Limited also earned a company secretarial fee of £7,500 (31 August 2018: £7,500; 28 February 2019: £15,000).

 

Calculus Capital Limited has taken on the expenses cap from 15 December 2015. For the 6 months to 31 August 2019, Calculus Capital Limited contributed £15,705 (31 August 2018: £15,204; 28 February 2019: £nil).

 

At 31 August 2019, there was £57,427 owed to Calculus Capital Limited (31 August 2018: £55,566; 28 February 2019: £54,445).

 

 

11. Transactions with Investment Managers

 

John Glencross, a Director of the Company, is considered to be a related party due to his position as Chief Executive and a director of Calculus Capital Limited, the Company's Investment Manager. He does not receive any remuneration from the Company. He is a director of Terrain Energy Limited.

 

Calculus Capital Limited receives a fee from certain portfolio companies. In the year the 31 August 2019, Calculus Capital charged a monitoring fee to , AnTech Limited, Arcis Biotechnology Holdings Limited, Arecor Limited, Blu Wireless Technology, Cloud Trade Technologies, Cornerstone Brands Limited, Duvas Technologies Limited, Essentia Analytics Limited, Every1Mobile Limited, IPV Limited, MicroEnergy Generation Services Limited, Mologic Limited, Money Dashboard Limited, Open Energy Market Limited, Oxford Biotherapeutics Limited, Park Street Shipping Limited, Quai Administration Services, Solab Group Limited, Synpromics Limited, Terrain Energy Limited, Tollan Energy Limited, Wazoku Limited, Weeding Technologies Limited and WheelRight Limited.

 

Calculus Capital Limited charged a fee for the provision of a director to Cloud Trade Technologies, Cornerstone Brands Limited, Essentia Analytics, Every1Mobile Limited, Open Energy Market, Pico's Limited, Terrain Energy Limited, Wazoku Limited, Weeding Technologies Limited and WheelRight Limited

 

Calculus Capital Limited charged an arrangement fee for certain portfolio companies. In the year 31 August 2019 Calculus Capital Limited charged an arrangement fee to Every1Mobile Limited and Wazoku Limited.

 

Calculus Capital Limited also charged Terrain Energy Limited for the provision of office support services.

 

The amount received by Calculus Capital which relates to the Company's investment was:

 

 

31 August 2019

£

31 August 2018

£

28 February 2019

£

Air Leisure Group Limited

-

1,189

2,377

AnTech Limited

262

507

255

Arcis Biotechnology Holdings Limited

91

94

187

Arecor Limited

375

-

2,712

Blu Wireless Technology Limited

1,314

-

-

Cloud Trade Technologies Limited

2,080

6,000

7,717

Cornerstone Brands Limited

1,620

1,560

3,120

Duvas Technologies Limited

694

6,249

7,212

Essentia Analytics Limited

1,396

-

4,785

Every1Mobile Limited

1,298

1,364

2,727

IPV Limited

192

-

-

MicroEnergy Generation Services Limited

1,014

967

1,964

MIP Diagnostics Limited

-

-

6,000

Mologic Limited

378

6,177

4,394

Money Dashboard Limited

341

348

696

Open Energy Market Limited

1,387

1,155

2,489

Origin Broadband Limited

-

663

678

Oxford Biotherapeutics Limited

1,550

5,999

8,402

Park Street Shipping Limited

533

475

974

Pico's Limited

557

4,638

5,283

Quai Administration Services Limited

698

559

1,013

Solab Group Limited

1,732

2,093

4,050

Synpromics Limited

180

145

290

Terrain Energy Limited

1,956

1,659

3,708

Tollan Energy Limited

-

1,659

1,669

Wazoku Limited

10,050

-

-

Weeding Technologies Limited

1,013

1,177

1,812

WheelRight Limited

628

-

658

 

12. Post balance sheet events

 

On 6 September 2019, the Company issued 1,334,399 Ordinary Shares under the prospectus approved on 13 September 2019. The Company subsequently launched a new offer 24 September 2019.

 

Other than as disclosed above, there have been no post balance sheet events.

 

 

 

COMPANY INFORMATION

 

Directors

Fund Administrator

Jan Ward

Link Alternative Fund Administrators Limited

Kate Cornish-Bowden

Beaufort House

John Glencross

51 New North Road

Claire Olsen

Exeter EX4 4EP

 

 

 

 

Registered Office

Auditors

104 Park Street

BDO LLP

London

55 Baker Street

W1K 6NF

London W1H 7EH

Telephone: 020 7493 4940

 

 

Broker

Company Number

Nplus1 Singer Advisory LLP

07142153

One Hanover Street

 

London W1S 1YZ

 

 

 

Venture Capital Investments Manager

And Company Secretary

Registrars

Calculus Capital Limited

The City Partnership (UK) Limited

104 Park Street

110 George Street

London W1K 6NF

Edinburgh

Telephone: 020 7493 4940

EH2 4LH

Website: www.calculuscapital.com

Telephone: 0131 243 7210

 

 

 

 

Sponsor

Beaumont Cornish Limited

29 Wilson Street

London EC2M 2SJ

Telephone: 0207 628 3396

 

 

 

 

 

 

 

 

 

Legal Entity Identifier: 2138005SMDWLMMNPVA90

 

Printed copies of the Calculus VCT plc Half Yearly Report for the six months ended 31 August 2019 have not been posted to shareholders. However, a copy can be found on the following website: http://www.calculuscapital.com/calculus-vct

 

 

For further information, please contact:

 

Calculus Capital Limited

Telephone: 020 7493 4940

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on this announcement (or any other website) are incorporated into, or form part of, this announcement.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR GGGBPUUPBGAR
Date   Source Headline
5th Apr 20242:54 pmRNSIssue of Equity - 5 April 2024
22nd Feb 20244:38 pmRNSDirectorship Change
15th Feb 202411:53 amRNSIssue of Equity - 15 February 2024
1st Feb 20244:38 pmRNSNet Asset Value - 31 December 2023
10th Jan 20245:27 pmRNSTransaction in Own Shares
21st Dec 202310:08 amRNSDirectorate Change
15th Dec 20233:25 pmRNSIssue of Equity - 15 December 2023
20th Nov 20232:11 pmRNSSeptember 2023 NAV Announcement
13th Nov 20234:46 pmRNSHalf-year Report
22nd Sep 20231:03 pmRNSPublication of a Prospectus
21st Sep 20233:51 pmRNSAppointment of Auditor
7th Sep 20234:57 pmRNSTransaction in Own Shares
30th Aug 202311:28 amRNSStatement re Intention to Raise
25th Aug 20231:19 pmRNSIssue of Equity
21st Aug 20233:25 pmRNSAGM and GM Statement
21st Jul 202312:13 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20233:04 pmRNSPublication of Circular and Notice of GM
3rd Jul 20235:43 pmRNSMay 2023 NAV Announcement
30th Jun 20232:15 pmRNSAnnual Financial Report & Change in Year-End date
5th Apr 20234:52 pmRNSIssue of Equity
5th Apr 20232:40 pmRNSIssue of Equity
15th Mar 20232:45 pmRNSIssue of Equity
9th Mar 20235:31 pmRNSTransaction in Own Shares
9th Mar 20237:00 amRNSTransaction in Own Shares
16th Dec 20223:41 pmRNSIssue of Equity
9th Dec 20225:06 pmRNSNet Asset Value(s)
18th Oct 202211:45 amRNSHalf-year Report
21st Sep 20222:34 pmRNSPublication of a Prospectus
31st Aug 20221:11 pmRNSIssue of Equity
29th Jul 202212:05 pmRNSTotal Voting Rights
14th Jul 20222:48 pmRNSRESULTS OF ANNUAL GENERAL MEETING
30th Jun 20222:03 pmRNSIssue of Equity
29th Jun 20222:37 pmRNSDirector Declaration
29th Jun 202211:45 amRNSNet Asset Value(s)
10th Jun 20225:12 pmRNSTransaction in Own Shares
1st Jun 20227:00 amRNSAnnual Financial Report
5th Apr 202212:23 pmRNSIssue of Equity
22nd Mar 20221:40 pmRNSIssue of Equity
1st Feb 20223:59 pmRNSNet Asset Value(s)
17th Dec 20211:08 pmRNSShare allotment and Total Voting Rights
12th Nov 20214:30 pmRNSTransaction in Own Shares
25th Oct 202112:00 pmRNSHalf yearly unaudited financial report
13th Sep 202112:12 pmRNSPublication of a Prospectus
2nd Sep 202110:30 amRNSIssue of Equity
6th Aug 20212:57 pmRNSChange of Registered Office
30th Jul 20211:18 pmRNSIssue of Equity
8th Jul 20215:07 pmRNSResult of Annual General Meeting
30th Jun 20213:38 pmRNSIssue of Equity and Total voting rights
17th Jun 202110:58 amRNSUnaudited Net Asset Value as at 31 May 2021
15th Jun 20219:18 amRNSCorrection to the AGM notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.